PHATHOM PHARMACEUTICAL

Phathom Pharmaceuticals Reports First Quarter 2021 Results and Provides Recent Business Updates

11 5 2021 07:00:04 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

06 5 2021 16:48:26 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

29 4 2021 15:01:00 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference

06 4 2021 07:00:02 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress

30 3 2021 15:05:01 提供 Nasdaq GlobeNewswire

Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Helicobacter pylori (H. pylori) Trial

19 1 2021 07:30:00 提供 Nasdaq GlobeNewswire